BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7513467)

  • 1. Acceptance of donor-specific islet allografts in rat by intraportal preimmunization with islets and FK 506.
    Yasunami Y; Ryu S; Ueki M; Arima T; Ikeda S; Kamei T
    Transplant Proc; 1994 Apr; 26(2):722. PubMed ID: 7513467
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term survival of Wistar-Furth islet allografts in Lewis rats is associated with spontaneously tolerated orthotopic liver allografts.
    Wan X; Yu W; Yang H; al-Abdullah I; Coddington D; Bitter-Suermann H; Wright JR
    Transplant Proc; 1994 Apr; 26(2):723-4. PubMed ID: 8171625
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term survival of islet allografts in diabetic rats treated with FK 506.
    Tze WJ; Tai J; Cheung SS; Murase N; Ricordi C; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3208-10. PubMed ID: 1721411
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of donor-specific unresponsiveness in rat islet allografts by FK 506.
    Yasunami Y; Ryu S; Ueki M; Konomi K
    Transplant Proc; 1992 Jun; 24(3):1037. PubMed ID: 1376510
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
    Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
    [No Abstract]   [Full Text] [Related]  

  • 6. Injection of bone marrow cells into the thymus to achieve tolerance in an islet xenotransplant (human-to-rat) model.
    Dellagiacoma G; Rossi M; Castagna MT; Radin S; Vecchioni R
    Transplant Proc; 1994 Jun; 26(3):1114-5. PubMed ID: 8029850
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of intrathymic induction of tolerance in outbred rat strains.
    Weide LG
    Transplant Proc; 1994 Dec; 26(6):3327-8. PubMed ID: 7998157
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraportal FK 506 improves intrahepatic islet allograft survival.
    Wang X; Berezniak R; Tafra L; Posselt A; Barker CF; Dafoe DC
    Transplant Proc; 1991 Dec; 23(6):3211-2. PubMed ID: 1721412
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of immune rejection in rat islet allografts by continuous SC administration of FK 506 using a mini-osmotic pump.
    Ryu S; Yasunami Y
    Transplant Proc; 1991 Feb; 23(1 Pt 1):760. PubMed ID: 1703710
    [No Abstract]   [Full Text] [Related]  

  • 10. FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats.
    Tze WJ; Tai J; Cheung SS; Ricordi C; Murase N; Starzl TE
    Transplant Proc; 1992 Jun; 24(3):1034-6. PubMed ID: 1376509
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of short-term FK 506 therapy on pancreas transplantation in rats.
    Ohtsuka S; Hayashi S; Sato E; Tanaka Y; Hachisuka T; Haba T; Taira N; Orihara A; Uchida K; Kano T
    Transplant Proc; 1991 Dec; 23(6):3217-8. PubMed ID: 1721413
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides.
    Zeng Y; Torres M; Wang Y; Montag A; Thistlethwaite JR
    Transplant Proc; 1995 Feb; 27(1):176-7. PubMed ID: 7878961
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressive and diabetogenic effect of FK 506 on pancreatic islet xenotransplantation.
    Yumiba T; Chui AK; Hibbins M; Stewart H; Hawthorne WJ; Chapman JR; Allen R; O'Connell PJ
    Transplant Proc; 1995 Jun; 27(3):2181-2. PubMed ID: 7540780
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerance of islet allografts induced by orthotopic liver transplantation.
    Sawada T; Asanuma Y; Furuya T; Saito K; Koyama K
    J Surg Res; 1999 Aug; 85(2):209-16. PubMed ID: 10423321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local immunologic factors determine the occurrence of primary nonfunction of islet xenografts.
    Marquet RL; Bouwman E; Bonthuis F; Wolvekamp MC; Kouwenhoven E; van Rooijen N; Scheringa M; Ijzermans JN
    Transplant Proc; 1994 Apr; 26(2):766-7. PubMed ID: 8171654
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of the immunosuppressive activity of FK 506 in rat islet allografts.
    Yasunami Y; Ryu S; Kamei T
    Transplant Proc; 1990 Apr; 22(2):875. PubMed ID: 1691557
    [No Abstract]   [Full Text] [Related]  

  • 17. Islet xenografts in mice and rats: I. Exocrine tissue is detrimental to engraftment and survival of human islet xenografts.
    Nicolae M; Ketchum RJ; Jahr H; Janoff H; Brayman KL
    Transplant Proc; 1994 Apr; 26(2):774. PubMed ID: 8171657
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary nonfunction of porcine islets of Langerhans in the thymus of diabetic rats without immunosuppression.
    de Villa VH; Cienfuegos JA; Hernandez JL; Pardo F; Benito C; Balen E; Saez E; Alava E
    Transplant Proc; 1992 Dec; 24(6):2984-5. PubMed ID: 1466024
    [No Abstract]   [Full Text] [Related]  

  • 19. Augmented survival of purified islet xeno- and allografts with reduced numbers.
    Gotoh M; Maki T; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):984. PubMed ID: 3152654
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
    Rastellini C; Cicalese L; Leach R; Braun M; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1999; 31(1-2):646-7. PubMed ID: 10083278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.